Disruption of the function of tumor-suppressor gene p53 by the hepatitis B virus X protein and hepatocarcinogenesis (original) (raw)

References

• Arii M, Takada S, Koike K (1992) Identification of three essential regions of hepatitis B virus X protein for transactivation function. Oncogene 7:397–403
  PubMed Google Scholar
• Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Presinger AC, Jessup JM, Vantuinen P, Ledbetter D, Barker DF, Nakamura Y, White R, Vogelstein B (1989) Chromosome 17 deletion and p53 gene mutations in colorectal carcinomas. Science 244:217–221
  PubMed Google Scholar
• Beasley RP, Hwang LY, Lin CC, Chien CS (1981) Hepatocellular carcinoma and hepatitis B virus. Lancet II:1129–1133
  Google Scholar
• Brechot C, Hadchouel M, Scotto J, Degos F, Charnay P, Trepo C, Tiollais P (1981a) Detection of hepatitis B virus DNA in liver and serum: a direct appraisal of the chronic carrier state. Lancet II:765–767
  Google Scholar
• Brechot C, Hadchouel M, Scotto J, Fonck M, Potet F, Vyas GN, Tiollais P (1981b) State of hepatitis virus DNA in hepatocyte of patients with hepatitis B surface antigen-positive and-negative liver diseases. Proc Natl Acad Sci USA 78:3906–3910
  PubMed Google Scholar
• Colgrove R, Sinon G, Ganem D (1989) Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J Virol 63:4019–4026
  PubMed Google Scholar
• Dejian A, Soningo P, Wain-Hobson S, Tiollais P (1984) Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat. Proc Natl Acad Sci USA 81:5350–5354
  PubMed Google Scholar
• Dignam JD, Lebovitz RM, Reoder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475–1489
  PubMed Google Scholar
• Feitelson MA, Zhu M, Duan LX, London WT (1993) Hepatitis B X antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8:1109–1117
  PubMed Google Scholar
• Finlay YT, Hinds PW, Levine AJ (1988) The P53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083–1093
  Google Scholar
• Hohne M, Schaefer S, Scifer M, Feitelson MA, Paul D, Gerlich WH (1990) Malignant transformation of immortalized transgenic hepatocyte after transfection with hepatitis B virus DNA. EMBO J 9:1137–1145
  PubMed Google Scholar
• Jameel S, Siddiqui A, Maguire HF, Rao KV (1990) Hepatitis B virus X protein produced in Escherichia coli is biologically functional. J Virol 64:3963–3966
  PubMed Google Scholar
• Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B (1991) Identification of p53 as a sequence-specific DNA-binding protein. Science 252:1708–1711
  PubMed Google Scholar
• Kim CM, Koike K, Saito I, Miyamura T, Jay G (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317–320
  PubMed Google Scholar
• Kobayashi M, Koike K (1984) Complete nucleotide sequence of hepatitis B virus DNA of subtype_adr_ and its conserved gene organization. Gene 30:227–232
  PubMed Google Scholar
• Koike K, Kobayashi M, Yaginuma K, Shirakata Y (1987) Structure and function of integrated HBV DNA. In: Robinson WS, Koike K, Will H (eds) Hepadona viruses. Liss, New York, pp 267–286
  Google Scholar
• Koike K, Shirakata Y, Yaginuma K, Arii M, Takada S, Akamura I, Hayashi Y, Kawada M, Kobayashi M (1989) Oncogenic potential of hepatitis B virus. Mol Biol Med 6:151–160
  PubMed Google Scholar
• Lascowski M Jr, Kato I (1990) Protein inhibitors of proteinases. Annu Rev Biochem 49:593–626
  Google Scholar
• Liu X, Miller CW, Koeffler PH, Berk AJ (1993) The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription. Mol Cell Biol 13:3291–3300
  PubMed Google Scholar
• Masuda H, Miller C, Koeffler PH, Battifora H, Cline MJ (1989) Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci USA 84:7716–7719
  Google Scholar
• Maxam AM, Gilbert W (1980) A new method for sequencing DNA. Proc Natl Acad Sci USA 74:560–564
  Google Scholar
• Nagaya T, Nakamura T, Tokino T, Tsurimoto T, Imai M, Mayumi T, Kamino K, Yamamura K, Matsubara K (1987) The mode of hepatitis virus DNA integration in chromosome of human hepatocellular carcinoma. Genes Dev 1:773–782
  PubMed Google Scholar
• Nakamura I, Koike K (1992) Identification of a binding protein to the X gene promoter region of hepatitis B virus. Virology 191:533–540
  PubMed Google Scholar
• Patel NU, Jameel S, Isom H, Siddiqui A (1989) Interactions between nuclear factors and hepatitis B virus enhancer. J Virol 63:5293–5301
  PubMed Google Scholar
• Popper H, Roth L, Purcell RH, Tennant BC, Gerin JL (1987) Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc Natl Acad Sci USA 84:866–870
  PubMed Google Scholar
• Prokocimer M, Shaklai M, Beb Bassat H, Wolf D, Goldfinger N, Rotter V (1986) Blood 68:113–118
  PubMed Google Scholar
• Ritter SE, Whittem TM, Quets AT, Schloemer RH (1989) An internal domain of the hepatitis B virus X antigen is necessary for transactivating activity. Virology 182:841–845
  Google Scholar
• Runkel L, Fischere M, Schaller H (1993) Two-codon insertion mutations of the HBx define two separate regions necessary for its transactivation function. Virology 197:529–536
  PubMed Google Scholar
• Seto E, Benedict Yen TS, Matija Perterlin B, Ou J-H (1988) Transactivation of the hman immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci USA 85:8286–8290
  PubMed Google Scholar
• Seto E, Mitchell PJ, Yen TSB (1990) Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 344:72–74
  PubMed Google Scholar
• Seto E, Usheva A, Zambetti GP, Momand J, Horikoshi N, Weinmann R, Levine A, Shenk T (1992) Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci USA 89:12028–12032
  PubMed Google Scholar
• Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503–517
  PubMed Google Scholar
• Spandau D, Lee CH (1988) Trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol 62:427–434
  PubMed Google Scholar
• Takada S, Koike K (1990a) Transactivation function of a 3′-truncated gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc Natl Acad Sci USA 87:5628–5632
  PubMed Google Scholar
• Takada S, Koike K (1990b) X protein of hepatitis B virus resembles a serine protease inhibitor. Jpn J Cancer Res 81:1191–1194
  PubMed Google Scholar
• Takada S, Koike K (1990c) Trans-activation fucction of 3′ truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc Natl Acad Sci USA 87:5628–5632
  PubMed Google Scholar
• Takada S, Koike K (1994) Three sites of the hepatitis B virus X protein cooperatively interact with cellular proteins. Virology 205:503–510
  PubMed Google Scholar
• Takada S, Gotoh Y, Hayashi S, Yoshida M, Koike K (1990) Structural rearrangement of integrated hepatitis B virus DNA as well as cellular flanking DNA is present in chronically infected hepatitis tissues. J Virol 64:822–828
  PubMed Google Scholar
• Thut CJ, Chen JL, Kiemm R, Tjian R (1995) p53 transcriptional activation mediated by co-activators TAFII40 and TAFII60. Science 267:100–104
  PubMed Google Scholar
• Tiollais P, Pourcell C, Dejean A (1985) The hepatitis B virus. Nature 317:489–495
  PubMed Google Scholar
• Twu J, Schloemer R (1987) Transcriptional trans-activating function of hepatitis B virus. J Virol 61:3448–3453
  PubMed Google Scholar
• Unger T, Shaul Y (1990) The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element. EMBO J 9:1889–1895
  PubMed Google Scholar
• Wang XW, Forrester K, Yeh E, Feitelson MA, Gu J-R (1994) Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 91:2230–2234
  PubMed Google Scholar
• Weintraub H, Hauschka S, Tapscott SJ (1991) The MCK enhancer contains a p53 responsive element. Proc Natl Acad Sci USA 88:4570–4571
  PubMed Google Scholar
• Wollersheim M, Debelka U, Hofschneider PH (1988) A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene 3:545–552
  PubMed Google Scholar
• Yaginuma K, Kobayashi M, Yoshida E, Koike K (1985) Hepatitis virus integration in hepatocellular carcinoma DNA: duplication of cellular flanking sequences at the integraton site. Proc Natl Acad Sci USA 82:4458–4462
  PubMed Google Scholar
• Yaginuma K, Kobayashi H, Kobayashi M, Morishima T, Matsuyama K, Koike K (1987) Multiple integration site of hepatitis B virus DNA in hepatocellular carcinoma and chronic active hepatitis from children. J Virol 61:1808–1813
  PubMed Google Scholar
• Yaginuma K, Nakamura I, Takada S, Koike K (1993) A transcription initiation site for the hepatitis B virus X gene is directed by the promoter-binding protein. J Virol 67:2559–2565
  PubMed Google Scholar
• Zeimer M, Garcia P, Shaul Y, Rutter WJ (1985) Sequence of hepatitis B virus DNA incorporated into the genome of a human hepatoma cell line. J Virol 53:885–892
  PubMed Google Scholar

Download references